Benzathine Penicillin G

PreclinicalSmall molecule

NNational Taiwan University Hospital

Benzathine Penicillin G is one of 11 small molecule programs targeting Syphilis. It is currently in Preclinical.

Indications

Total Trials

Active Trials

Competitors

Pipeline

Status by Indication[3][1]

Indication

SyphilisActive, not recruiting

SyphilisPreclinical

Active, not recruiting

Competition

Competitive Landscape

19 competitors in Syphilis

#DrugCompanyPhaseTrials

Vibramycin

PPfizer's Upjohn has merged with Mylan to form Viatris Inc.

Approved

6 2

Suprax

WWyeth-Lederle Vaccines

Approved

2 3

Rocephin

CConrado Roberto Hoffmann Filho

Approved

1 4

Zyvox

Pfizer

Phase 3

1 5

Amoxil

GGlobal Antibiotics Research and Development Partnership

Phase 3

3 6

Zithromax

PPfizer's Upjohn has merged with Mylan to form Viatris Inc.

Phase 3

1 7

Benzathine Penicillin

NNational Institute of Allergy and Infectious Diseases (NIAID)

Phase 3

3 8

Penicillin-G-Benzathine

Pfizer

Phase 3

1 9

Benzathine Penicilllin G

FFundación FLS de Lucha Contra el Sida, las Enfermedades Infecciosas y la Promoción de la Salud y la Ciencia

Ceftriaxone Sodium

Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.

Timeline

Expected Milestones

Q2 2027

Recruiting

Pregnancy

NCT07207876

Phase 2Not yet recruiting

Syphilis

NCT06921213

Q4 2028

N/ARecruiting

Syphilis

NCT06069141

Clinical

Trials by Indication[1]

Syphilis5 trials

Comparisons of Treatment Responses of Early Syphilis to Benzathine Penicillin G With or Without Doxycycline

Recruiting·NNational Taiwan University Hospital·N/A·NCT06069141·688 enrolled

One Dose Versus Three Weekly Doses of Benzathine Penicillin G for Patients With Early Syphilis

Unknown status·JJun Li·Phase 4·NCT02857959·150 enrolled

Treatment Responses of Early Syphilis to Ceftriaxone Plus Doxycycline

Terminated·NNational Taiwan University Hospital·Phase 4·NCT05980871·109 enrolled

Show 2 more trials

Comprehensive Ambulatory Antibiotics for the Treatment of Congenital Syphilis

Not yet recruiting·LLondon School of Hygiene and Tropical Medicine·Phase 2·NCT06921213·90 enrolled

Cefixime for Alternative Syphilis Treatment

Completed·UUniversity of California, Los Angeles·Phase 2·NCT03660488·58 enrolled

Treatment1 trial

The Association Between Molecular Typing of Treponema Pallidum and Treatment Efficacy and Clinical Findings

Unknown status·PPeking Union Medical College Hospital·Phase 4·NCT02871505·150 enrolled

Pregnancy1 trial

Study of Ceftriaxone and Benzathine Penicillin G During Pregnancy

Recruiting·IInternational Maternal Pediatric Adolescent AIDS Clinical Trials Group··NCT07207876·110 enrolled

Sources

References

[1]
ClinicalTrials.gov — 7 trial records for Benzathine Penicillin G. U.S. National Library of Medicine, National Institutes of Health.
[2]
ChEMBL — Benzathine Penicillin G compound record. European Bioinformatics Institute (EMBL-EBI).
[3]
Open Targets Platform — Drug–disease associations for Benzathine Penicillin G. EMBL-EBI & Wellcome Sanger Institute.
[4]
SEC EDGAR — National Taiwan University Hospital company filings. U.S. Securities and Exchange Commission.

Details

Drug Info

Quick Facts

Modality: Small molecule[2]
Highest Phase: Preclinical[1]
Company: NNational Taiwan University Hospital

Benzathine Penicillin G

Status by Indication[3][1]

Competitive Landscape

Expected Milestones

Q2 2027

Q4 2028

Trials by Indication[1]

Syphilis5 trials

Treatment1 trial

Pregnancy1 trial

References

Drug Info

Quick Facts

Related News